Literature DB >> 21401994

Prescribing antidepressants for depression: time to be dimensional and inclusive.

Ian M Anderson1, Peter M Haddad.   

Abstract

The article by Middleton and Moncrieff questions the role of antidepressants in treating depression on both philosophical and practical grounds; namely that depression isn't a brain disease to be treated by a drug and that antidepressants are ineffective except as placebos. We argue that their stance is unhelpful and factually incorrect and that a more dimensional and integrative approach is needed in order to be able to best tailor treatment to individual needs. This involves a personalised assessment of the likely benefits and risks of both psychological and drug approaches when recommending treatment for someone with depression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401994      PMCID: PMC3020051          DOI: 10.3399/bjgp11X548992

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  11 in total

1.  Clinical trials of antidepressant medications are producing meaningless results.

Authors:  Gordon Parker; Ian M Anderson; Peter Haddad
Journal:  Br J Psychiatry       Date:  2003-08       Impact factor: 9.319

2.  An analysis of therapist treatment effects: toward providing feedback to individual therapists on their clients' psychotherapy outcome.

Authors:  John C Okiishi; Michael J Lambert; Dennis Eggett; Lars Nielsen; David D Dayton; David A Vermeersch
Journal:  J Clin Psychol       Date:  2006-09

3.  Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials.

Authors:  D Lynch; K R Laws; P J McKenna
Journal:  Psychol Med       Date:  2009-05-29       Impact factor: 7.723

4.  'They won't do any harm and might do some good': time to think again on the use of antidepressants?

Authors:  Hugh Middleton; Joanna Moncrieff
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

5.  Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.

Authors:  K A Smith; J S Morris; K J Friston; P J Cowen; R J Dolan
Journal:  Br J Psychiatry       Date:  1999-06       Impact factor: 9.319

Review 6.  Affective cognition and its disruption in mood disorders.

Authors:  Rebecca Elliott; Roland Zahn; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

7.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.

Authors:  H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

Review 8.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

9.  Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.

Authors:  T Kendrick; J Chatwin; C Dowrick; A Tylee; R Morriss; R Peveler; M Leese; P McCrone; T Harris; M Moore; R Byng; G Brown; S Barthel; H Mander; A Ring; V Kelly; V Wallace; M Gabbay; T Craig; A Mann
Journal:  Health Technol Assess       Date:  2009-04       Impact factor: 4.014

10.  Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Irving Kirsch; Brett J Deacon; Tania B Huedo-Medina; Alan Scoboria; Thomas J Moore; Blair T Johnson
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

View more
  4 in total

1.  Improving Access to Psychological Therapies and antidepressant prescribing rates in England: a longitudinal time-series analysis.

Authors:  Vaishnavee Sreeharan; Hugo Madden; John Tayu Lee; Christopher Millett; Azeem Majeed
Journal:  Br J Gen Pract       Date:  2013-09       Impact factor: 5.386

2.  Antidepressant prescribing.

Authors:  John Nichols
Journal:  Br J Gen Pract       Date:  2011-03       Impact factor: 5.386

3.  Antidepressant prescribing.

Authors:  Philip Rathbone
Journal:  Br J Gen Pract       Date:  2011-03       Impact factor: 5.386

4.  An end to depression in primary care?

Authors:  Andrew Moscrop
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.